Margo Christiane Funk, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Torsades de Pointes | 3 | 2022 | 79 | 1.880 |
Why?
|
Long QT Syndrome | 3 | 2022 | 466 | 1.650 |
Why?
|
Psychiatry | 4 | 2022 | 1689 | 0.920 |
Why?
|
Referral and Consultation | 3 | 2020 | 3598 | 0.550 |
Why?
|
Psychotropic Drugs | 2 | 2020 | 883 | 0.540 |
Why?
|
Physicians, Women | 1 | 2022 | 495 | 0.530 |
Why?
|
Buprenorphine | 1 | 2023 | 654 | 0.500 |
Why?
|
Physician's Role | 1 | 2020 | 918 | 0.430 |
Why?
|
Opioid-Related Disorders | 1 | 2023 | 2138 | 0.310 |
Why?
|
Pacemaker, Artificial | 1 | 2013 | 815 | 0.290 |
Why?
|
Heart-Assist Devices | 1 | 2016 | 1291 | 0.240 |
Why?
|
Physicians | 1 | 2022 | 4591 | 0.230 |
Why?
|
Defibrillators, Implantable | 1 | 2013 | 1499 | 0.220 |
Why?
|
Telemedicine | 1 | 2020 | 3018 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.200 |
Why?
|
Internship and Residency | 1 | 2022 | 5870 | 0.200 |
Why?
|
Bradycardia | 1 | 2022 | 299 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8624 | 0.170 |
Why?
|
Citalopram | 1 | 2022 | 402 | 0.170 |
Why?
|
Opiate Substitution Treatment | 1 | 2023 | 436 | 0.160 |
Why?
|
Hospitals, General | 1 | 2023 | 795 | 0.160 |
Why?
|
Bundle-Branch Block | 1 | 2021 | 281 | 0.160 |
Why?
|
Aggression | 1 | 2022 | 745 | 0.140 |
Why?
|
Electrocardiography | 2 | 2021 | 6414 | 0.140 |
Why?
|
Mental Disorders | 1 | 2016 | 6796 | 0.130 |
Why?
|
Workplace | 1 | 2022 | 857 | 0.130 |
Why?
|
Renal Dialysis | 1 | 2022 | 1801 | 0.110 |
Why?
|
Uterine Cervical Dysplasia | 2 | 2007 | 384 | 0.110 |
Why?
|
Heart Failure | 1 | 2016 | 11847 | 0.090 |
Why?
|
Career Choice | 1 | 2017 | 754 | 0.090 |
Why?
|
Body Image | 1 | 2016 | 635 | 0.090 |
Why?
|
Automobile Driving | 1 | 2016 | 438 | 0.090 |
Why?
|
Self Care | 1 | 2016 | 793 | 0.090 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 2363 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2007 | 2003 | 0.080 |
Why?
|
Curriculum | 1 | 2022 | 3718 | 0.080 |
Why?
|
Heart Ventricles | 1 | 2021 | 3811 | 0.080 |
Why?
|
Humans | 13 | 2023 | 760621 | 0.080 |
Why?
|
Preoperative Care | 1 | 2016 | 2256 | 0.070 |
Why?
|
DNA-Binding Proteins | 2 | 2022 | 9585 | 0.070 |
Why?
|
Anxiety Disorders | 1 | 2016 | 2714 | 0.060 |
Why?
|
Students, Medical | 1 | 2017 | 1927 | 0.060 |
Why?
|
Delirium | 1 | 2016 | 1663 | 0.060 |
Why?
|
Terminal Care | 1 | 2016 | 1758 | 0.060 |
Why?
|
Depressive Disorder | 1 | 2016 | 3726 | 0.050 |
Why?
|
Chromosome Aberrations | 2 | 2006 | 1764 | 0.050 |
Why?
|
Heart Transplantation | 1 | 2016 | 3224 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5325 | 0.050 |
Why?
|
Decision Making | 1 | 2016 | 3925 | 0.050 |
Why?
|
Immunoglobulins | 1 | 2005 | 859 | 0.050 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2004 | 397 | 0.050 |
Why?
|
Radiation Tolerance | 1 | 2004 | 480 | 0.050 |
Why?
|
Comorbidity | 1 | 2016 | 10551 | 0.050 |
Why?
|
Guanine | 1 | 2002 | 278 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2002 | 321 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2005 | 1055 | 0.040 |
Why?
|
Genomic Instability | 1 | 2004 | 704 | 0.040 |
Why?
|
Gene Silencing | 1 | 2005 | 1513 | 0.040 |
Why?
|
Adenine | 1 | 2002 | 975 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2007 | 4573 | 0.030 |
Why?
|
Child | 1 | 2022 | 79806 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2007 | 8515 | 0.030 |
Why?
|
Risk Factors | 1 | 2020 | 74359 | 0.030 |
Why?
|
DNA Damage | 1 | 2002 | 2442 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2007 | 4024 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2007 | 9411 | 0.020 |
Why?
|
Female | 6 | 2022 | 391270 | 0.020 |
Why?
|
Neoplasm Invasiveness | 2 | 2007 | 3618 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2007 | 3775 | 0.020 |
Why?
|
DNA | 1 | 2002 | 7233 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2005 | 7850 | 0.020 |
Why?
|
Microdissection | 1 | 2007 | 151 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2007 | 749 | 0.010 |
Why?
|
Spermatocytes | 1 | 2004 | 40 | 0.010 |
Why?
|
Colony-Forming Units Assay | 1 | 2004 | 351 | 0.010 |
Why?
|
Lasers | 1 | 2007 | 952 | 0.010 |
Why?
|
Epithelium | 1 | 2007 | 1605 | 0.010 |
Why?
|
Promoter Regions, Genetic | 2 | 2005 | 5785 | 0.010 |
Why?
|
Stromal Cells | 1 | 2007 | 1326 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2007 | 1755 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2006 | 1745 | 0.010 |
Why?
|
Gene Targeting | 1 | 2004 | 839 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2005 | 12766 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 2005 | 1602 | 0.010 |
Why?
|
HeLa Cells | 1 | 2005 | 3105 | 0.010 |
Why?
|
Telomere | 1 | 2004 | 933 | 0.010 |
Why?
|
Hot Temperature | 1 | 2004 | 1435 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 4107 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 25942 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2005 | 2802 | 0.010 |
Why?
|
DNA Repair | 1 | 2004 | 2039 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2004 | 2828 | 0.010 |
Why?
|
Cell Survival | 1 | 2004 | 5797 | 0.010 |
Why?
|
Binding Sites | 1 | 2002 | 6048 | 0.010 |
Why?
|
Gene Expression | 1 | 2004 | 7588 | 0.010 |
Why?
|
DNA Methylation | 1 | 2005 | 4373 | 0.010 |
Why?
|
Protein Binding | 1 | 2002 | 9335 | 0.010 |
Why?
|
Cell Line | 1 | 2004 | 15620 | 0.010 |
Why?
|
United States | 1 | 2017 | 72461 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2004 | 14372 | 0.000 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 16939 | 0.000 |
Why?
|
Male | 2 | 2017 | 359744 | 0.000 |
Why?
|
Adult | 1 | 2017 | 219994 | 0.000 |
Why?
|
Mice | 1 | 2004 | 81208 | 0.000 |
Why?
|
Animals | 1 | 2004 | 167963 | 0.000 |
Why?
|